Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Expression analysis of immune-regulatory molecules HLA-G, HLA-E and IDO in endometrial cancer
Hamza Ben Yahia, Nadia Boujelbène, Wafa Babay, et al.
Human Immunology (2020) Vol. 81, Iss. 6, pp. 305-313
Closed Access | Times Cited: 15

Showing 15 citing articles:

Harnessing the potential of HLA-G in cancer therapy: advances, challenges, and prospects
Siyuan Wang, Jiaxin Wang, Yu Xia, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 11
HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges
Aifen Lin, Wei‐Hua Yan
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 49
HLA-G and Other Immune Checkpoint Molecules as Targets for Novel Combined Immunotherapies
Fabio Morandi, Irma Airoldi
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 2925-2925
Open Access | Times Cited: 30
HLA and tumour immunology: immune escape, immunotherapy and immune-related adverse events
Ning Jiang, Yue Yu, Dawei Wu, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 2, pp. 737-747
Closed Access | Times Cited: 16
Narrative review of the relationship between the maternal-fetal interface immune tolerance and the onset of preeclampsia
Fangyuan Luo, Jun Yue, Lingling Li, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 12, pp. 713-713
Open Access | Times Cited: 10
Establishment of a N1-methyladenosine-related risk signature for breast carcinoma by bioinformatics analysis and experimental validation
Leilei Li, Wenhui Yang, Daqi Jia, et al.
Breast Cancer (2023) Vol. 30, Iss. 4, pp. 666-684
Open Access | Times Cited: 4
HLA-G - evolvement from a trophoblast specific marker to a checkpoint molecule in cancer, a narrative review about the specific role in breast- and gynecological cancer
Julia Knabl, Ye Yao, Gernot Desoyé, et al.
Journal of Reproductive Immunology (2024) Vol. 166, pp. 104385-104385
Open Access | Times Cited: 1
HLA-G and single nucleotide polymorphism (SNP) associations with cancer in African populations: Implications in personal medicine
Ismael Adolf, Amany I. Almars, Nazima Dharsee, et al.
Genes & Diseases (2021) Vol. 9, Iss. 5, pp. 1220-1233
Open Access | Times Cited: 9
Human leukocyte antigen‐G in gynaecological tumours
Xinmeng Guo, Jinning Zhang, Jin Shang, et al.
International Journal of Immunogenetics (2023) Vol. 50, Iss. 4, pp. 163-176
Open Access | Times Cited: 3
Chasing Uterine Cancer with NK Cell-Based Immunotherapies
Vijay Kumar, Caitlin Bauer, John H. Stewart
Future Pharmacology (2022) Vol. 2, Iss. 4, pp. 642-659
Open Access | Times Cited: 4
Effect of MHC Linked 7-Gene Signature on Delayed Hepatocellular Carcinoma Recurrence
Fomaz Tariq, Walizeb Khan, Washaakh Ahmad, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 11, pp. 1129-1129
Open Access | Times Cited: 3
Nobel Prize for immune checkpoint inhibitors, understanding the immunological switching between immunosuppression and autoimmunity
Ion G. Motofei
Expert Opinion on Drug Safety (2021) Vol. 21, Iss. 5, pp. 599-612
Closed Access | Times Cited: 3
HLA-G: A Novel Immune Checkpoint for Solid Cancer Immunotherapy
Aifen Lin, Wei‐Hua Yan
Springer eBooks (2023), pp. 1-27
Closed Access
Roles of cancer stem cells in cancer immune surveillance
Nhat Chau Truong, Nhi Huynh, Kmuong-Duy PHAM, et al.
Minerva Biotechnology and Biomolecular Research (2023) Vol. 35, Iss. 1
Closed Access
Immune Checkpoint Inhibitors (ICI) in Advanced and Recurrent Endometrial Cancer
Chinmoy K Bose
Indian Journal of Gynecologic Oncology (2022) Vol. 20, Iss. 1
Closed Access
Page 1

Scroll to top